» Articles » PMID: 29063337

Mast Cells in Renal Cancer: Clinical Morphological Correlations and Prognosis

Overview
Publisher Springer
Specialty General Medicine
Date 2017 Oct 25
PMID 29063337
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Morphofunctional activity of mast cells in renal cancer is studied on specimens from the center of the tumor, peritumorous zone (with an obligatory fragment of the pseudocapsule), and from renal tissues maximally distant from the tumor. The counts and areas of tumor cells were maximum in the peritumorous zone in comparison with intact kidney tissue and central zone of the tumor. Analysis of correlations revealed a direct correlation between the tumor cell count in the peritumorous zone and some clinical morphological parameters of the tumor (anaplasia degree, size, presence of invasion and metastases, and angiogenesis). The count of mast cells in the renal peritumorous zone inversely correlated with 5-year survival: 100% cumulative 5-year survival in patients with mast cell count <6.7±1.6 per field of view.

Citing Articles

The immune microenvironment of cancer of the uterine cervix.

Mastrogeorgiou M, Chatzikalil E, Theocharis S, Papoudou-Bai A, Peoch M, Mobarki M Histol Histopathol. 2024; 39(10):1245-1271.

PMID: 38483012 DOI: 10.14670/HH-18-727.


Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review.

Sofia D, Zhou Q, Shahriyari L Bioengineering (Basel). 2023; 10(11).

PMID: 38002445 PMC: 10669004. DOI: 10.3390/bioengineering10111320.


Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.

Sulsenti R, Jachetti E Pharmaceutics. 2023; 15(6).

PMID: 37376140 PMC: 10303176. DOI: 10.3390/pharmaceutics15061692.


Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway.

Che X, Li J, Xu Y, Wang Q, Wu G Front Genet. 2022; 13:953322.

PMID: 36186427 PMC: 9519989. DOI: 10.3389/fgene.2022.953322.


M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.

Qu X, Zhao X, Lin K, Wang N, Li X, Li S Front Immunol. 2022; 13:994019.

PMID: 36177006 PMC: 9513313. DOI: 10.3389/fimmu.2022.994019.